Member Area
Join
Institutional
Join
Annuity
Code of ethics
Committees
Board
Representations
Who we are
Social
Access to Medicines
Equity
Patient Information
One Blood
Education
Events
Hemoteca
HEMO PLAY Podcast
HEMO.Educa
Webinars
Science
Consensus
Guidelines
Clinical Studies Platform
Registry
HTCT Sientific Magazine
Career
Young Blood
Medical Residency Support Program
Titles and certifications
Vacancies and Opportunities
Quality
Accreditation
Communication
ABHH in magazine
ABHH Connection
News
Consensus
Genetically Modified Cells
Patient Blood Management
Sickle Cell Disease
Management of Acute Promyelocytic Leukemia
Thalassemia
I. Structuring of Centers for clinical application and multidisciplinary management of patients with CAR-T cells
II. CAR T cell therapy for adult and child patients with CD19+ acute lymphoid leukemia
III. Anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma
IV. CAR T cell therapy for patients with multiple myeloma
V. Quality control and manufacturing
VI. Accreditation Process
VII. Present and future of technologies for the production of CAR cell therapies
VIII. Preclinical models for the development of CAR T cell therapies (in vitro and in vivo models)
Review Article: Compassionate Use and Clinical Trial of CAR-T Cells
Review Article: Cell Therapy in Solid Tumors
Special Article: Advanced therapy products in Brazil: regulatory overview
Download the PDF
Download the PDF
Download the PDF
Download the PDF
